MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Genetics"

  • 2025 International Congress

    A Case of SGCE Myoclonus-Dystonia diagnosed in a 70-Year-Old Male

    V. Mazo, P. Atit, N. Shneyder, N. Rincon-Flores (Tampa, USA)

    Objective: N/A Background: SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by myoclonus and dystonia, primarily affecting the neck, trunk, and upper limbs. Patients may…
  • 2025 International Congress

    GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

    T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To describe the clinical presentation, diagnostic evaluation, and genetic findings in a 7-year-old male with a hyperkinetic movement disorder associated with a novel GNAI1…
  • 2025 International Congress

    Neurological manifestations and genotypes of Gaucher disease type 3: MDSGene systematic review

    S. Schaake, T. Usnich, J. Boehm, N. Steffen, N. Schell, C. Krüger, T. Gül-Demirkale, N. Bahr, T. Kleinz, H. Madoev, B. Laabs, Z. Gan-Or, R. Alcalay, C. Marras, K. Lohmann, C. Klein, M. Rossi (Luebeck, Germany)

    Objective: To characterize the spectrum of neurological manifestations of Gaucher disease type 3 (GD3) and identify the most common GBA1 variants. Background: Gaucher disease is…
  • 2025 International Congress

    Dentatorubral–Pallidoluysian Atrophy (DRPLA) : A case series of nine patients from western India

    K. Bavdhankar, P. Agarwal, N. Jain, S. Kothari, A. Soni, S. Kharat, A. Shah, S. Jagtap (Mumbai, India)

    Objective: To study the clinicoradiological and genetic profile of confirmed Dentatorubral–Pallidoluysian Atrophy (DRPLA) cases in Western India Background: DRPLA is a hereditary disease caused due to trinucleotide repeat…
  • 2025 International Congress

    Autosomal Dominant DHDDS-Related Movement Disorder Treated with Primidone

    D. Dewey, M. Khalaf, M. Hoerth, M. Osundiji, J. Caviness, S. Chiu (Scottsdale, USA)

    Objective: To describe novel clinical features and treatment response in a patient with neurodevelopmental disorder due to variants in dehydrodolichol diphosphate synthetase (DHDDS). Background: DHDDS…
  • 2025 International Congress

    The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights

    S. Polet, L. Siegal, S. Fuchs, M. Tijssen, T. de Koning (Groningen, Netherlands)

    Objective: Mutations in the GOSR2 gene are associated with North Sea-Progressive Myoclonus Epilepsy (NS-PME). Because more recently additional phenotypes have been described we systematically reviewed…
  • 2024 International Congress

    Mechanism Study of Familial Cortical Myoclonic Tremor with Epilepsy Type 1 Caused by Pentanucleotide Repeat Expansion in the SAMD12 Gene

    Z-D. Cen, F. Zhang, Y-L. Chen, X-H. Chen, W. Luo (Hangzhou, China)

    Objective: This study aims to explore the pathogenic mechanisms of familial cortical myoclonic tremor with epilepsy (FCMTE) using various cellular models, from the perspectives of…
  • 2024 International Congress

    Childhood onset progressive myoclonus and ataxia in a patient with novel TBC1D2B gene mutation

    M. Gultekin, N. Basak (Kayseri, Turkey)

    Objective: Myoclonus, ataxia, tremor and dystonia have been described in some patients with TBC1D2B gene mutation. In this paper we present a patient with progressive…
  • 2024 International Congress

    Expanding the phenotypic spectrum of movement disorders in 22q11.2 deletion syndrome

    N. Reyes, T. Cortez-Grippe, M. Callister, T. Heung, A. Bassett, A. Lang (Toronto, Canada)

    Objective: To formally characterize the evolving spectrum of movement disorders associated with chromosome 22q11.2 deletion syndrome Background: Emerging evidence suggests that a wide range of…
  • 2024 International Congress

    Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy

    C. Del Gamba, E. Bieth, S. Kaya, E. Leitão, K. Astudillo, S. Frucht, C. Depienne, G. Riboldi (New York City, USA)

    Objective: To describe the first case of Familial adult myoclonic epilepsy 3 (FAME3) due to intermediate intronic expansion of MARCHF6. Background: FAME is an autosomal…
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley